snbts management board - Scottish National Blood Transfusion ...

More documents

Recommendations

Info

APPROVED VERSION2.5 Core System Replacement – Ref Item 5.3The possibility of using suppliers to provide interface rather than develop this inhouse will be discussed in more detail at the April meeting.LL, MB2.6 MHRA INSPECTIONSDr Cuthbertson reported that a strategy had been agreed with the MHRA inresponse to their recent inspection of the USA plasma supplier. Themanufacturer would continue to supply product until the end of the contract.Two shipments were due and it was noted that a two week extension to thecontract may be required.3 NATIONAL DIRECTOR’S REPORTB 10.47 3.1 MONTHLY UPDATEIn presenting the National Director’s report Mr Thompson covered the followingmeetings:- SNBTS Partnership – 12th February• The Partnership Working template had been deferred for furtherdiscussion. NSS Partnership – 16th February• Every member of staff in the pension scheme should have receivedinformation regarding the Pensions Choice Action Plan from theScottish Public Pensions Agency and workshops were beingarranged by NSS to assist decision making• The Business Case in respect of Meridian Court had been revisitedand would be submitted to the NSS Board on 7th May. It wasproposed that Meridian Court would house PSD, HPS and HFS. Apolicy of desk sharing had been included in the revised plans• The following policies had been approved:-o NSS Fire Safety Policyo NSS Recruitment and Selectiono NSS Reserve Forces Training and Mobilisation Policyo Lone Working EMT – 23rd February• An SNBTS local delivery plan which would allow for some serviceimprovement had been discussed at NSS and it was important thatif the work is to be completed in the financial year that there shouldbe no delays in implementing this• NSS Environmental Strategy had been approved• NSS Governance Arrangements are to be circulated to SNBTSManagement Board members• The SNBTS Extracorporeal Photopheresis (ECP) Programme hadbeen discussed and the method of approving funding for this andsimilar projects. This had gone forward to the NationalCommissioning Group for review UK Forum – 26th February• JPAC has been asked to prepare a Business Plan and MrThompson will write to Dr Sheila MacLennan and Dr Mike Murphy.• It had been agreed that the Prion Assay Working Group (PAWG)and the Prion Reduction Working Group (PRWG) should be mergedand the combined prion group will be chaired by Professor Turner• Professor Franklin is to continue representing the UK on the EBAuntil the end of 2010• SNBTS had been invited by the Department of Health to participatein a UK short life working group on Stem Cell provision General Issues – 3rd MarchMS2
APPROVED VERSION• A verbal indication to proceed with the implementation of 80%apheresis platelets had been given and Mr Thompson wouldprovide a letter of explanation to SGHD• The availability of leaflets explaining how to become a bone marrowdonor and the work with the Anthony Nolan Trust had beendiscussed• The approach to public petitions and how to raise SNBTS profilehad been reviewed• Fernbrae hospital is to be put on notice as they had failed to signthe Service Level Agreement required by SNBTS to comply withtheir license.4 ITEMS FOR APPROVALB 10.48 4.1 Finance2010-2011 BudgetingA second Resource Allocation meeting had been held on 4th March concerningthe 2010-2011 budgets. A reduction of the projected revenue deficit from£1.7m to £1.1m had been possible by using the sale of waste plasma to meetthe cost of non-recurring expenditure. Likewise a review of the capitalrequirements had been requested and by bringing forward some expenditureand deferring others the total had been reduced by £384k. It was noted thatsignificant savings were projected from the Service Modernisation programme.A workforce plan including the move to 80% apheresis had been completedand was being used to project costs for 2010-2011. LEAN efficiencies hadinitially been targeted at the donor services and processing and testing butcould be extended to other SNBTS Directorates, especially clinical.2009-2010 ReportingA net surplus of £1m for the year to date was projected. The surplus had beenaccounted for as a result of vacancies in both Quality and Clinical, the impactof the sale of plasma, and slippage on some developments.Considerable work on delivering projects within the year and bringing forwardsome expenditure into 2009-2010 had taken place resulting in a total forecastcapital spend of £2.7m for 2010-2011.Mr Stillie noted that under Agenda for Change On Call Payments and ShiftPremiums had not been dealt with and back payments to staff accruing from2005 would be due in the coming year. A rough calculation of the amountoutstanding had been made and it was estimated that this could be in theregion of £1m plus.B 10.49 4.2 Policy Testing of Blood and Tissue Donors using Multiplex NATThe proposed policy had been discussed at the recent Clinical Governanceand Safety Committee and a review meeting would be held the following day todecide on a go live date.After some further discussion it was agreed that the algorithm should besimplified. SOPs are still to be finalised.Mr Thompson had requested a breakdown of costs for both routine andconfirmatory reference work and these had still to be done.BCCP,BD,MBB 10.50 4.3 Policy NSS National Health, Safety and WellbeingThe NSS policy on Health, Safety and Wellbeing was submitted for information.3
Page 1: APPROVED VERSIONB 10.65SNBTS MANAGE
Page 5 and 6: APPROVED VERSIONare to be heard bef
Page 7: APPROVED VERSIONA copy of the Minut

snbts management board - Scottish National Blood Transfusion ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?